Your shopping cart is empty!
CBD oil (cannabidiol) is a certified lipophilic hemp extract based on MCT or hemp oil for sublingual administration. UATRAVA products (5%–30%) contain strictly 0.0% THC, are laboratory-certified (COA), and are legal in Ukraine. They provide 20–35% bioavailability within 15–25 minutes, effectively reducing anxiety, improving sleep, and relieving pain without a psychoactive effect.
CBD Oil 10% (1000 mg) About the product CBD oil 10% is a natural product based on pure cannabidiol ..
CBD Oil 20% (2000 mg) About the product CBD oil 20% is a highly concentrated natural product contai..
CBD Oil 5% (500 mg) About the product CBD oil 5% is a natural remedy for maintaining physical and e..
CBD Oil - Natural Support for Your Health CBD oil is a natural plant extract enriched with cannabidi..
CBD oil 15% - natural extract from hemp for your health CBD oil is a natural extract obtained from c..
CBD 2% Oil - Natural Support for Daily Balance CBD oil with a concentration of 2% is a soft and bala..
CBD Oil 2% for animals - natural support for the health and comfort of your pet This hemp oil with c..
CBD Oil - Natural Hemp Extract for Health and Balance CBD oil is a natural plant product derived fro..
CBD oil - natural plant extract 20% for health support Cannabidiol (CBD) is one of the main active i..
CBD oil 3.3% (1000 mg) is a natural remedy for global body support, created on the basis of cannabid..
CBD Oil 5% - a natural remedy for comprehensive support of the body CBD oil is a concentrated cannab..
CBD Oil 5% for Animals Pets are our friends, family members with whom we share joys and worries. Th..
What is CBD Oil Isolate 20% and how does it differ from other formats? CBD Oil Isolate 20% is a conc..
What is CBD Oil Isolate 25% and how is it different from other forms? CBD Oil Isolate 25% is a conce..
What is CBD Oil Isolate 30% and how does it differ from other formats? CBD Oil Isolate 30% is one of..
The original CBD oil in the UATRAVA online store catalog is a standardized, pharmaceutical-grade cannabidiol extract dissolved in an organic lipid carrier—coconut MCT oil (medium-chain triglycerides C8/C10) or unrefined, cold-pressed hemp oil. Sublingual administration (inserting drops under the tongue for 60–90 seconds) ensures direct diffusion of cannabidiol molecules into the systemic circulation via the sublingual venous plexus ( vena sublingualis ). This pharmacokinetic pathway completely eliminates first -pass metabolism in the liver, achieving a therapeutic bioavailability of 20–35% within 15–25 minutes of administration.
For those looking to buy CBD oil in Ukraine and Kyiv, we offer products with proven clinical efficacy: healing CBD oil drops for sleep and anxiety help restore balance to the endocannabinoid system (ECS), gently alleviating stress-related exhaustion, normalizing slow-wave sleep, and relieving chronic muscle spasms. Our specialized line offers carefully calibrated CBD oil concentrations of 5%, 10%, 15%, 20%, and 30% in medical-grade amber glass bottles with precision-measuring droppers. All products contain 0.0% THC (in accordance with Cabinet of Ministers Resolution No. 770), are non-narcotic, and are certified by independent laboratories (COA protocols).
Sublingual administration of cannabidiol oil drops is recognized in evidence-based phytopharmacology as the standard non-invasive method for delivering the active ingredient. The mucous membrane of the sublingual region of the oral cavity has a unique histological structure: thin, nonkeratinized stratified squamous epithelium is underlain by loose connective tissue with an exceptionally dense network of fenestrated capillaries and sublingual veins ( vena sublingualis ). When the solution is applied and held under the tongue for 60–90 seconds, non-polar cannabidiol molecules passively diffuse through the lipid bilayer of membranes directly into the venous bloodstream.
The main pharmacokinetic advantage of sublingual delivery is its complete bypass of the gastrointestinal tract and elimination of the so-called first-pass hepatic clearance effect. With standard ingestion (e.g., capsules or gummies), up to 85–90% of cannabidiol is metabolized and inactivated by liver microsomal enzymes of the cytochrome P450 system (primarily CYP3A4 and CYP2C19 isoenzymes), resulting in a critical drop in systemic bioavailability of 6–13%. In contrast, with sublingual absorption, dissolved CBD enters the superior vena cava and systemic circulation directly through the vena sublingualis , providing systemic bioavailability of 20–35% within 15–25 minutes of instillation.
Once in the systemic circulation, CBD molecules exhibit multifactorial pharmacological activity within the endocannabinoid system (ECS) . Cannabidiol is not a direct agonist of cannabinoid type 1 (CB1) receptors, unlike psychoactive THC, but acts as a negative allosteric modulator. By altering the spatial conformation of the CB1 receptor, CBD prevents its hyperstimulation, suppressing neuronal excitability and restoring the physiological balance of GABA and glutamate neurotransmitters in the central nervous system. Simultaneously, CBD activates peripheral CB2 receptors expressed on immune cells, suppressing the transcription of proinflammatory cytokines (TNF-α, interleukins IL-1β, and IL-6) and reducing systemic inflammation.
An additional clinical mechanism is the direct agonism of cannabidiol to serotonin 5-HT1A receptors and modulation of TRPV1 ion channels, which ensures a pronounced anxiolytic, analgesic and neuroprotective effect without suppressing the respiratory center and cognitive functions.
Pharmacokinetic parameter
Sublingual administration (oil under the tongue)
Oral administration (capsules/gummies)
Inhalation (CBD Vape)
Bioavailability of the active substance
20% – 35%
6% – 13%
40% – 55%
Time of first effect
15 – 25 minutes
45 – 90 minutes
1 – 3 minutes
First-pass hepatic metabolism
Completely excluded
Extensive metabolism (CYP450)
Duration of the therapeutic window
4 – 6 hours
6 – 8 hours
1.5 – 3 hours
Stress on the gastrointestinal tract
Zero
Present (enzymes, bile)
In UATRAVA's laboratory practice and catalog, oil grading is based on the phytochemical integrity of the cannabinoid profile, obtained using gentle supercritical CO2 extraction. This low-temperature, liquefied CO2 technology allows for the extraction of heat-labile phytocompounds without thermal degradation or the use of toxic hydrocarbon solvents (butane, hexane, or propane).
Depending on the subsequent stages of molecular purification and distillation, we divide the preparations into three technological classes:
Evaluation parameter
Full Spectrum
Broad Spectrum
Pure Isolate (CBD Isolate 99.8%)
Cannabinoid profile
CBD + CBG, CBN, CBC, CBDV
CBD + CBG, CBN, CBC
Exclusively CBD molecule (≥99.8%)
Terpene complex
Full native profile (myrcene, caryophyllene)
Saved completely
Completely removed
Entourage Effect
Maximum clinical potential (100%)
High synergistic response (85–90%)
Absent (mono-component action)
Tetrahydrocannabinol content
Trace (<0.08%, non-psychoactive)
Absolutely Zero (0.0% THC-Free)
Organoleptic profile
Rich, herbaceous, coniferous, tart
Soft natural aroma
Neutral taste, no cannabis smell
Target audience
Chronic pain, insomnia, migraines
Anxiety, athletes, drivers
High allergenicity, precise dosage calculation
Cannabidiol is a highly lipophilic, hydrophobic molecule: it is insoluble in water and requires a stable lipid solvent to penetrate biological membranes. UATRAVA's product range utilizes two reference organic oil bases, each with distinct biological properties:
The pharmacological efficacy of cannabidiol is strictly dose-dependent. Each original 10 ml bottle in the UATRAVA catalog comes with a certified graduated medical glass pipette with a contrasting graduation scale (0.25 ml, 0.5 ml, 0.75 ml, 1.0 ml). A standard 1.0 ml bottle contains approximately 20–22 drops of oil solution.
To accurately select your daily dose, our specialists have calculated a precision matrix of active cannabidiol content:
CBD strength (%)
Total CBD content (mg/10 ml)
CBD content in 1 drop (mg)
Contents in 0.5 ml pipette (mg)
Contents in 1.0 ml pipette (mg)
Clinical application profile
5%
500 mg
2.5 mg
25 mg
50 mg
Beginners, gentle stress prevention, ECS adaptation
10%
1,000 mg
5.0 mg
100 mg
"Gold Standard": Daily emotional stress, insomnia
15%
1,500 mg
7.5 mg
75 mg
150 mg
Chronic insomnia, anxiety disorders, frequent migraines
20%
2,000 mg
10.0 mg
200 mg
Severe joint pain, arthritis, deep depression
30%
3,000 mg
15.0 mg
300 mg
Therapeutic maximum: neuropathic pain, fibromyalgia
A properly selected concentration of CBD oil (5%, 10%, 15%, 20%, 30%) allows for precise dosing of the active substance: for example, to achieve a standard evening dose of 25 mg of CBD, it is enough to take 5 drops of 10% oil or just 2.5 drops of 20% concentrate.
Cannabidiol's pharmacodynamics are cumulative and modulating: it doesn't artificially "switch off" symptoms, but rather restores endogenous regulation through neurotransmitter cascades. Based on clinical trial data and the practical experience of UATRAVA consultants, we have developed three basic application protocols:
Each person's body has a unique density and sensitivity of cannabinoid receptors. We strongly recommend a gradual titration approach:
The safety and pharmacopoeial purity of our extracts are the cornerstone of UATRAVA's philosophy. We categorically reject products of artisanal or uncertified origin: every batch of oil featured in our catalog undergoes a comprehensive, multi-stage audit in accredited laboratories that comply with the European ISO/IEC 17025 standard.
For each batch of goods, an extended quality certificate is generated – a certificate of analysis (COA) , which confirms three key parameters:
Cannabidiol circulation in Ukraine is 100% legal. According to the List of Narcotic Drugs, Psychotropic Substances, and Precursors (Resolution of the Cabinet of Ministers of Ukraine No. 770, as amended) and Law of Ukraine No. 3528-IX, cannabidiol (CBD) is not included in the list of prohibited narcotic substances. Broad Spectrum products and isolate guarantee an absolute THC content of 0.0% (THC-free) , making them completely safe for inspection by regulatory authorities, departmental testing, or driving.
Many customers are interested in the fair price of CBD oil in Kyiv pharmacies, where reviews often point to inflated markups and a limited selection. In the UATRAVA catalog, you receive direct deliveries from leading certified manufacturers at a fair price (starting from 890 UAH per bottle), confirmed by hundreds of real customer reviews and open COA scans.
Return to table of contents ↑
Is CBD oil addictive or addictive?
Absolutely not. The official report of the World Health Organization (WHO Expert Committee on Drug Dependence) confirms that purified cannabidiol has no potential for abuse, does not cause physical or psychological dependence, and does not cause withdrawal symptoms. Unlike THC, cannabidiol does not stimulate the psychoactive centers of the cerebral cortex, does not cause euphoria, altered perception of reality, or decreased cognitive control.
Will a drug test show a positive result after a course of oil?
Standard immunochromatographic test strips and laboratory screenings (at drug treatment centers, patrol police, or medical examinations) react exclusively to tetrahydrocannabinol metabolites—the substance 11-nor-9-carboxy-THC. When consuming Broad Spectrum oils or isolates with a confirmed 0.0% THC level, the risk of a false positive result is reduced to zero.
What is the correct technique for placing oil under the tongue and how long should it be kept there?
Stand in front of a mirror, draw the desired dose into the graduated pipette, and direct the drops directly into the sublingual area (to the right or left of the frenulum). Do not swallow and hold the oil solution in your mouth for 60–90 seconds, allowing the cannabinoids to be absorbed through the venous network (vena sublingualis). Then swallow the remainder of the solution. For maximum absorption, refrain from smoking, drinking, or eating for 15 minutes after the procedure.
Is it possible to combine CBD oil with pharmaceutical medications?
Cannabidiol is broken down in the liver by the cytochrome 450 enzyme family (including CYP3A4 , CYP2C9 , and CYP2C19 ), temporarily competing for these enzymes with other pharmacological molecules. If you are taking anticoagulants, immunosuppressants, sedatives, or beta-blockers, be sure to maintain a time interval of at least 2 hours between taking the medication and CBD drops.
What strength and bottle size should I choose for my first encounter?
For the first course and adaptation of the endocannabinoid receptor system, our experts recommend a 10 ml bottle with a concentration of 5% (500 mg CBD) or 10% (1000 mg CBD). The 10% concentration is the universal gold standard: 1 drop provides exactly 5.0 mg of active cannabidiol, allowing for comfortable and precise titration of the daily dose.
At UATRAVA , we don't just provide access to a European range of cannabinoids—we take full responsibility for the predictability, safety, and therapeutic results of your treatment:
Get a personalized dosage estimate in 2 hours and order original CBD oil →